Cullinan Therapeutics, Inc. Common Stock (CGEM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CGEM. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 176 institutions reported holding CGEM, with 71.5 million shares worth $1.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Mpm Bioimpact | 9,731,341 | $177M | INCREASED |
| Lynx1 Capital Management | 8,963,500 | $163M | UNCHANGED |
| Bvf Inc/IL | 5,750,683 | $105M | UNCHANGED |
| BlackRock | 5,232,766 | $95M | INCREASED |
| T. Rowe Price | 3,825,950 | $70M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Cullinan Therapeutics, Inc. Common Stock on SentiSense.